PF-54898 |
FAMCICLOVIR Asmoh 250 mg Tabletas recubiertas |
2023-01-29 |
|
Krishpar Healthcare |
India
|
Krishpar Healthcare |
Medicalsa |
Centrino Pharma |
ERETZ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54987 |
CISPLATINO Krishpar 50 mg/50 mL Solución inyectable |
2023-03-05 |
|
Asmoh Laboratories Limited. |
India
|
Krishpar Healthcare |
Medicalsa |
Sada Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55017 |
CLARITROMICINA ASMOH 125 mg / 5 mL Polvo para Suspensión Oral |
2023-03-12 |
|
Asmoh Laboratories Limited. |
India
|
Krishpar Healthcare |
Medicalsa |
Sada Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55014 |
TEICOPLANINA Asmoh 400 mg Polvo Liofilizado para uso Parenteral |
2023-03-12 |
|
Asmoh Laboratories Limited. |
India
|
Krishpar Healthcare |
Medicalsa |
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55145 |
AMIODARONA ASMOH 200 mg Tabletas |
2023-04-05 |
|
Krishpar Healthcare |
India
|
Krishpar Healthcare |
Medicalsa |
Green Products |
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55387 |
VALSARTAN + AMLODIPINA Asmoh 160 mg/5 mg tabletas recubiertas |
2023-06-20 |
|
Krishpar Healthcare |
India
|
Krishpar Healthcare |
Medicalsa |
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55125 |
HIDROXIPROGESTERONA CAPROATO KRISHPAR 125 mg / mL Solución Inyectable |
2023-03-27 |
|
Asmoh Laboratories Limited. |
India
|
Krishpar Healthcare |
Green Products |
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55625 |
AMIODARONA Concentrado estéril ASMOH 50 mg/mL Solución inyectable |
2023-08-10 |
|
Asmoh Laboratories Limited. |
India
|
Cisa |
Krishpar Healthcare |
Medicalsa |
Centrino Pharma |
Repremedh Representaciones Médicas Hospitalarias |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55629 |
METOPROLOL Asmoh 100 mg Tableta |
2023-08-10 |
|
Asmoh Laboratories Limited. |
India
|
Krishpar Healthcare |
Green Products |
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56886 |
CEFOTAXIMA Asmoh 1g Polvo para solución inyectable |
2024-07-03 |
|
Krishpar Healthcare |
India
|
Krishpar Healthcare |
Medicalsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|